Drug Pricing Evolution in Hepatitis C

Article Article scientifique Article Drug Pricing Evolution in Hepatitis C eng 2016 author Vernaz-Hegi Nathalie 35221 author Girardin François 640429 author Goossens Nicolas 509893 author Brugger Ursula Liselotte 58016 author Riguzzi Marco author Perrier Arnaud 27944 author Negro Francesco 96509 e0157098 10.1371/journal.pone.0157098 27310294 1932-6203 We aimed to determine the association between the stepwise increase in the sustained viral response (SVR) and Swiss and United States (US) market prices of drug regimens for treatment-naive, genotype 1 chronic hepatitis C virus (HCV) infection in the last 25 years. We identified the following five steps in the development of HCV treatment regimens: 1) interferon (IFN)-α monotherapy in the early '90s, 2) IFN-α in combination with ribavirin (RBV), 3) pegylated (peg) IFN-α in combination with RBV, 4) the first direct acting antivirals (DAAs) (telaprevir and boceprevir) in combination with pegIFN-α and RBV, and 5) newer DAA-based regimens, such as sofosbuvir (which is or is not combined with ledipasvir) and fixed-dose combination of ritonavir-boosted paritaprevir and ombitasvir in combination with dasabuvir. Dewey 610/370 Dewey 616 Dewey 616.07 48 Unité de développement et de recherche en éducation médicale 204 137 Département de pathologie et immunologie 21F 56 Département de médecine 221 false 297 Etudes et traitement de l'hépatite C et B 554 302 Groupe Desmeules Jules (pharmacologie/toxicologie) 567 319 Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) 585 PloS one 11 6 2a9dcf88-63c3-4533-b6a8-ab3d88fd2eff Article (Published version) Public Negro.pdf 743229 application/pdf CC BY openAccess Faculté de médecine / Unité de développement et de recherche en éducation médicale Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Drug Pricing Evolution in Hepatitis C	PloS one			2016	1 304	581

Archive ouverte UNIGE

Brugger, Ursula Liselotte